Evidence map›Paper›PMID 32033501›Full record

SynthesisMedicina (Kaunas, Lithuania)2020

A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.

Jui-Yi Chen, Shih-Kai Wei, Chih-Cheng Lai, Teng-Song Weng, Hsin-Hua Wang

Open access · goldAbstract readComparative StudyMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. PA and PA-X: two key proteins from segment 3 of the influenza viruses.Frontiers in cellular and infection microbiology · 2025
    Review
  3. Article
  4. Antiviral Drugs in Influenza.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jui-Yi ChenDivision of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.
Shih-Kai WeiDepartment of Pharmacy, Chi Mei Medical Center, Liouying 73657, Tainan, Taiwan.
Chih-Cheng LaiDepartment of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch 71051, Tainan, Taiwan.
Teng-Song WengDepartment of Pharmacy, Chi Mei Medical Center, Liouying 73657, Tainan, Taiwan.
Hsin-Hua WangDepartment of Pediatrics, Chi Mei Medical Center, Liouying 73657, Tainan, Taiwan.
Chi Mei Medical Center · TWKaohsiung Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThis meta-analysis compared the efficacy and safety of peramivir compared to other neuraminidase inhibitors (NAIs).

Indexed as

Acids, CarbocyclicAntiviral AgentsCyclopentanesEnzyme InhibitorsGuanidinesHumansInfluenza, HumanNeuraminidaseObservational Studies as TopicOseltamivirRandomized Controlled Trials as TopicAcids, CarbocyclicAntiviral AgentsCyclopentanesEnzyme InhibitorsGuanidinesNeuraminidaseOseltamivirperamivirinfluenzaneuraminidase inhibitorsperamivir

Identifiers

PMID32033501
PMCPMC7073584
OpenAlexW3004959512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.